Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Autoimmune Disorders

  Free Subscription


04.05.2020

1 Am J Kidney Dis
6 Ann Neurol
2 BMC Neurol
3 J Clin Endocrinol Metab
2 J Neurol
1 Mult Scler
1 N Engl J Med
1 Neurol Genet
2 Neurology
3 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Kidney Dis

  1. REVUELTA A, Rivera-Villegas H, Carranza CA, Ramirez-Sandoval JC, et al
    A Case of New-Onset Nephrotic Syndrome.
    Am J Kidney Dis. 2020;75:A13-A15.
    PubMed        


    Ann Neurol

  2. JUREK B, Chayka M, Kreye J, Koelch M, et al
    Reply to "Pregnancy, N-Methyl-D-Aspartate Receptor Antibodies, and Neuropsychiatric Diseases".
    Ann Neurol. 2020;87:325-326.
    PubMed        

  3. ZEYDAN B, Kantarci K, Kantarci OH
    Reply to "Amyloid PET in Multiple Sclerosis: between amyloid deposition and myelin damage".
    Ann Neurol. 2020 Apr 30. doi: 10.1002/ana.25758.
    PubMed        

  4. CAI MT, Zheng Y, Zhang YX
    Grading the severity of autoimmune encephalitis: When to evaluate?
    Ann Neurol. 2020 May 1. doi: 10.1002/ana.25761.
    PubMed        

  5. DALMAU J
    Pregnancy, N-Methyl-D-Aspartate Receptor Antibodies, and Neuropsychiatric Diseases.
    Ann Neurol. 2020;87:324-325.
    PubMed        

  6. LEE ST, Lim JA, Chu K, Lee SK, et al
    Reply to "Grading the severity of autoimmune encephalitis: When to evaluate?"
    Ann Neurol. 2020 May 1. doi: 10.1002/ana.25760.
    PubMed        

  7. MATIAS-GUIU JA, Cabrera-Martin MN, Pytel V, Montero P, et al
    Amyloid PET in Multiple Sclerosis: between amyloid deposition and myelin damage.
    Ann Neurol. 2020 May 1. doi: 10.1002/ana.25759.
    PubMed        


    BMC Neurol

  8. ROMANELLI RJ, Huang Q, Lacy J, Hashemi L, et al
    Multiple sclerosis in a multi-ethnic population from Northern California: a retrospective analysis, 2010-2016.
    BMC Neurol. 2020;20:163.
    PubMed         Abstract available

  9. WIENEMANN T, Muller AK, MacKenzie C, Bielor C, et al
    Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report.
    BMC Neurol. 2020;20:158.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  10. MAKINEN M, Loyttyniemi E, Koskinen M, Vaha-Makila M, et al
    Serum 25-Hydroxyvitamin D Concentrations at Birth in Children Screened for HLA-DQB1 Conferred Risk for Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Jan 16. pii: 5289723. doi: 10.1210/jc.2018-02094.
    PubMed         Abstract available

  11. SHALIMOVA A, Graff B, Gasecki D, Wolf J, et al
    Cognitive Dysfunctions in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2019 Jan 18. pii: 5290155. doi: 10.1210/jc.2018-01315.
    PubMed         Abstract available

  12. SIMON MC, Moller-Horigome A, Strassburger K, Nowotny B, et al
    Correlates of Insulin-Stimulated glucose Disposal in Recent Onset Type 1 and Type 2 Diabetes.
    J Clin Endocrinol Metab. 2019 Jan 28. pii: 5303356. doi: 10.1210/jc.2018-02057.
    PubMed         Abstract available


    J Neurol

  13. CHEN MH, Wylie GR, Sandroff BM, Dacosta-Aguayo R, et al
    Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study.
    J Neurol. 2020 Apr 29. pii: 10.1007/s00415-020-09853.
    PubMed         Abstract available

  14. SABIN J, Urtiaga S, Pilo B, Thuissard I, et al
    Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
    J Neurol. 2020 Apr 29. pii: 10.1007/s00415-020-09848.
    PubMed         Abstract available


    Mult Scler

  15. FOX E, Lovett-Racke AE, Gormley M, Liu Y, et al
    A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
    Mult Scler. 2020 Apr 30:1352458520918375. doi: 10.1177/1352458520918375.
    PubMed         Abstract available


    N Engl J Med

  16. LUNDQUIST AL, Kalim S, Mojtahed A, Tomaszewski KJ, et al
    Case 13-2020: A 29-Year-Old Man with High Blood Pressure, Renal Insufficiency, and Hematuria.
    N Engl J Med. 2020;382:1639-1647.
    PubMed        


    Neurol Genet

  17. DEGASPERIS SM, Bernard G, Wolf NI, Miller E, et al
    4H leukodystrophy: Mild clinical phenotype and comorbidity with multiple sclerosis.
    Neurol Genet. 2020;6:e409.
    PubMed        


    Neurology

  18. ARUN T, Pattison L, Palace J
    Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study.
    Neurology. 2020 Apr 30. pii: WNL.0000000000009491.
    PubMed         Abstract available

  19. MATHIS S, Soulages A, Vallat JM, Le Masson G, et al
    History of acute polyradiculoneuropathy (part 1): The prehistory of Guillain-Barre syndrome.
    Neurology. 2020 Apr 28. pii: WNL.0000000000009401.
    PubMed         Abstract available


    PLoS One

  20. GOUGH N, Brkan L, Subramaniam P, Chiuccariello L, et al
    Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
    PLoS One. 2020;15:e0223029.
    PubMed         Abstract available

  21. GOLDMAN MD, Dwyer L, Coleman R, Sohn MW, et al
    Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.
    PLoS One. 2020;15:e0228617.
    PubMed         Abstract available

  22. HJORTH M, Dandu N, Mellergard J
    Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
    PLoS One. 2020;15:e0228380.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: